Pgi34 - A Cost Saving Measure From the Utilisation of Biosimilar Infliximab in the Irish Secondary Care Setting

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.876
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Efficacious Transition From Reference Infliximab to Biosimilar Infliximab in Clinical Practice

International Journal of Rheumatic Diseases
Rheumatology
2019English

Letter: Is There a Role for Infliximab Biosimilar in Patients With Inflammatory Bowel Disease With Secondary Loss of Response to Infliximab Innovator?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Gynaecological Robotic Surgery in an Irish Setting—cost Analysis

Gynecological Surgery
GynecologySurgeryObstetrics
2013English

Insights for Care: The Healthcare Utilisation and Cost Impact of Managing Diabetes-Associated Nephropathy and Neuropathy at a UK Secondary Care Hospital

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

PF-06438179/GP1111: An Infliximab Biosimilar

BioDrugs
MedicineBiotechnologyPharmacology
2018English

THU0218 the Efficacy and Drug Survival of the Biosimilar Infliximab (CT-P13) Compared to the Original Reference Infliximab in Inflammatory Rheumatic Diseases; Results From the Turkbio Registry

2018English

Pgi26 - Cost Saving Analysis of a Community Stoma Care Service

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Crystal Structures of PF-06438179/GP1111, an Infliximab Biosimilar

BioDrugs
MedicineBiotechnologyPharmacology
2019English

Evaluation of the Cost Saving Potential of Introducing an Etanercept Biosimilar (Benepali®) for the Treatment of All Licensed Adult Etanercept Indications in the UK

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy